The relation between concentration of thymolphthalein monophosphate substrate and catalytic activity was investigated for the determination of prostatic acid phosphatase. This study, an extension of previously reported work (Clin. Chem. 27: 1372 , 1981 , showsthat lot-to-lot variation in purity of thymolphthalein monophosphate preparations is reflected in substrate-velocity curves. Plateau regions in these curves at 1.5-2.5 gIL result from the combined effects of (a) Bowers et al. (3) reported on 14 lots of commercially available TMP and established several criteria of acceptability forTMP. We have used some of the substrates they described to study their respective substrate-velocity curves in the PAP reaction. Lot-to-lot comparisons were expedited with a protocol involving mixtures of both "test lot" TMP and a "reference lot" of TMP. This mixed-substrate approach allowed identification of minimally inhibiting lots of TMP.
Buffered substrate (2. 98 mg/mL TMP Na salt; 233 mrnol/L sodium acetate buffer, pH 5.4; . A buffered substrate solution was prepared as described by Ewen and Spitzer (2) in a 25-mL volumetric flask, consisting of 10 mL of a 8.75 g/L Brij-35 (detergent) solution, 74.50 ± 0.05 mg of disodium TMP, 792 mg of sodium acetate trihydrate, sufficient HC1 to bring the pH to 5.4, and water to volume. It was 
This solution was
prepared and used as described elsewhere (2) .
PAP in pooled human serum.
The enzyme preparation consisted of human seminal fluid in a serum pool at pH 6.5, prepared as previously described (3). This preparation was stored frozen and used freshly thawed.
Methods

Estimates
of true TMP concentrations from spectrophotometric and liquid-chromatographic analyses.
In previous investigations the chemical purity of several lots of TMP was so estimated (3) . Those data were used in the present work to calculate "purity indexes."
The following factors were used to correct weighed amounts of substrate for water and impurity content: lot A, (.97 The usual assay procedure was performed, except that we used mixtures of buffered substrate solutions prepared from different lots of TMP as substrate. To accomplish this, we first pipetted 300 L of the "reference" buffered substrate into the appropriate reaction tubes, followed by an additional 300 fLL of various dilutions of the "test" buffered substrate.
Nephelometry of reaction mixtures.
Reaction mixtures were prepared containing various concentrations of buffered substrate (0-3.0 mg/mL) plus various amounts of enzyme 
Results
Effect of substrate concentration on PAP activity.
The effect of various substrate concentrations (0.265 to 2.55 mg/mL) on observed PAP activity was characteristic for each lot of TMP, variations being particularly marked at the highest substrate concentrations ( Figure IA) . The presence of minima in the corresponding reciprocal plots (Figure 2 ) is consistent with noncompetitive or uncompetitive substrate (or contaminant) inhibition. However, the presence of congruent plateau regions near 1.0-1.5 mg of TMP per milliliter in all substrate-velocity curves suggests that additional factors are involved in determining observed PAP activity. To examine this effect, we re-plotted the same data, using TMP molar concentrations corrected for water and impurity content ( Figure 1B ). The maximal-activity plateaus are now displaced to concentration ranges characteristic for each lot of TMP tested.
A highly pure sample, lot A,5 supported the highest PAP activity, with a plateau in the curve corresponding to the region 1.5 to 2.5 mmol/L; this suggests that this may be the true optimal concentration .range for pure TMP. Other lots showed diminished activity in the same concentration range. Figure 1A ), addition of "test" lots of TMP affected the reaction velocity to an extent characteristic for each lot ( Figure 3 ). For example, lots C and E were more inhibitory than additional lot A (reference), while several lots were similar to or even slightly superior to the reference lot. Note that lots A and I were found "acceptable" by the criteria of Bowers et al. 
Discussion
Evaluation of various lots of TMP. Although physical and chemical criteria had been developed forevaluatingindividual lotsof TMP
(3), a means for understanding the inhibitory propertiesof each lotwas also desirable.Use of the mixedsubstrate protocol provides direct comparisons, which require fewer test points than are needed to generate complete inhibition curves.
Lots identified as "acceptable" and "unacceptable" by Bowers et al. (3) generallyexhibited lessor more inhibition, respectively, when compared with the reference lot at a total substrate concentration of 2.55 mg/mL (Figure 3 ). Only lot G lacked this correlation, showing less inhibition than lot A despite a previous unacceptable ranking. None of the lotsof substratetestedwas not inhibitory; all lots displayed optimal plateau regions at 1.0to 1.5mg/mL. For Inhibition studies.
All substrates tested, including those previously shown to be 99% pure TMP (3), showed the same pattern of apparent substrate product or contaminant inhibition. Comparisons of substrate-velocity data for one lot at three different reaction times indicate that accumulated product(s) is not a principal cause of decreased activity. Also, inhibition by TMP itself is inconsistent with the observation that lot purity is directly proportional to maximal activity and indirectly related to inhibitory behavior (Figure 1 ). If strongly inhibitory contaminants were uniquely responsible, those lots with the least inhibitor would show optima at the highest concentration of substrate, whether expressed as weight or molarity. However, Figure 1 indicates that the inhibition is independent of the mass concentration of substrate. Nephelometric studies.
All substrate-velocity curves plateaued at similar mass concentrations of substrate; thus it was possible that the "inhibition" might actually be physical substrate depletion caused by aggregate formation of TMP and associated impurities at high concentrations. Probable contaminants in the substrate include thymolphthalein, and several mono-and di-phosphorylated isomers, species of similar structure and low solubility. The similarity in structure and solubility was evidenced in part by the work of Bowers et al. (3) , where similar liquid-chromatographic behavior and similar chromogenicity of the various contaminants were observed. If aggregate formation were to involve nonspecific reactions of several such species in the substrate, then the plateau would be seen at similar weight concentrations of substrate regardless of the TMP content of the lots investigated. Moreover, the height of each maximal activity plateau would depend on the molar TMP concentration available at, the 1.0-2.5 mg/L solubility limit of the substrate.
This theory was tested conveniently by using the rate nephelometer, albeit in a mode not usually used for clinical measurements. In the scatter mode, this instrument records light-scattering properties of a specimen in arbitrary units, although itdoes not afford a quantitative determination of the size of the scattering species.
Dilutions of two very different lots (A and E) of TMP in buffered substrate were examined and low constant scatter was observed. However, with addition of 10 L of enzyme pool the results shown in Figure 4 were obtained. The most crucial result is that there was a sharp break in the light-scattering curve. Most interestingly, the mass concentrationof substrate at which thisbreak occurred was identicalfor the reference lot and the impure lot;furthermore, this concentration is identical to the concentration at the minima of their respective Lineweaver-Burke reciprocal plots. The break in the lightscattering curve may thus represent the crossover point at which larger aggregates are formed. These aggregates apparently involve both serum components and substrate components, because diluted substrate alone, serum alone, or diluent buffer alone shows neither the high levels of scatter nor the break in the curve.
We conclude that it is critical that PAP activity be directly related to the available molar concentration of TMP at all attainable substrate mass concentrations. Errors in estimated TMP concentration because of lot-to-lot variation in purity will be directly reflected in the measured PAP activity. The additional complication of aggregate formation serves to amplify the need more fully to explore kinetic parameters when specific lots of substrate are being selected for clinical use.
